A&G Pharmaceutical
Developer of linked therapeutic and diagnostic products (theranostics) focused on cancer. The company reports capabilities in monoclonal antibody discovery and engineering, tumor-specific biomarker discovery, and co-development of companion diagnostics together with targeted therapeutics to support earlier detection, patient selection, and monitoring of treatment response.
Industries
Nr. of Employees
small (1-50)
A&G Pharmaceutical
Patents
Materials and methods for the development of an antigen-specific immune non-responsiveness state
US-11801287-B2
View DetailsMonoclonal antibodies and conjugates against prostaglandin F2 receptor inhibitor and uses thereof
US-11555074-B2
View Details
Materials and methods for the development of an antigen-specific immune non-responsiveness state
US-11801287-B2
View DetailsMonoclonal antibodies and conjugates against prostaglandin F2 receptor inhibitor and uses thereof
US-11555074-B2
View DetailsProducts
Monoclonal antibody targeting progranulin (research use)
A monoclonal antibody directed against human progranulin described for research use in breast cancer, other cancers, and other diseases.
PROGRANULIN
Proprietary monoclonal antibody against human for research use in breast cancer, other cancers, and diseases.
Monoclonal antibody targeting progranulin (research use)
A monoclonal antibody directed against human progranulin described for research use in breast cancer, other cancers, and other diseases.
PROGRANULIN
Proprietary monoclonal antibody against human for research use in breast cancer, other cancers, and diseases.
Services
Co-development of linked diagnostics and targeted therapeutics based on tumor-specific biomarkers to support patient selection, monitoring, and treatment optimization.
Co-development of linked diagnostics and targeted therapeutics based on tumor-specific biomarkers to support patient selection, monitoring, and treatment optimization.
Expertise Areas
- Theranostics (Rx-Dx co-development)
- Monoclonal antibody development
- Biomarker discovery
- Diagnostic assay development
Key Technologies
- Monoclonal antibody engineering
- Biomarker discovery platform
- Companion diagnostic assays
- Cell biology and immunology methods